Review of daclizumab and its therapeutic potential in the treatment of relapsing–remitting multiple sclerosis

Por Reardon, Jennifer, Perumal, Jai S
Publicado em 2013

Fingolimod and cardiac risk: latest findings and clinical implications

Por Vargas, Wendy S, Perumal, Jai S
Publicado em 2013

Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis

Por Babij, Rachel, Perumal, Jai S
Publicado no Neuropsychiatr Dis Treat (2015)

Disease exacerbation after rituximab induction in neuromyelitis optica

Por Perumal, Jai S., Kister, Ilya, Howard, Jonathan, Herbert, Joseph
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)

A study of patients with aggressive multiple sclerosis at disease onset

Por Kaunzner, Ulrike W, Kumar, Gaurav, Askin, Gulce, Gauthier, Susan A, Nealon, Nancy N, Vartanian, Timothy, Perumal, Jai S
Publicado no Neuropsychiatr Dis Treat (2016)

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE

Por Perumal, Jai, Fox, Robert J., Balabanov, Roumen, Balcer, Laura J., Galetta, Steven, Makh, Shavy, Santra, Sourav, Hotermans, Christophe, Lee, Lily
Publicado no BMC Neurol (2019)

Design, Rationale, and Baseline Characteristics of the Randomized Double-Blind Phase II Clinical Trial of Ibudilast in Progressive Multiple Sclerosis

Por Fox, Robert J., Coffey, Christopher S., Cudkowicz, Merit E, Gleason, Trevis, Goodman, Andrew, Klawiter, Eric C, Matsuda, Kazuko, McGovern, Michelle, Conwit, Robin, Naismith, Robert, Ashokkumar, Akshata, Bermel, Robert, Ecklund, Dixie, Koepp, Maxine, Long, Jeffrey, Natarajan, Sneha, Ramachandran, Srividya, Skaramagas, Thomai, Thornell, Brenda, Yankey, Jon, Agius, Mark, Bashir, Khurram, Cohen, Bruce, Coyle, Patricia, Delgado, Silvia, Dewitt, Dana, Flores, Angela, Giesser, Barbara, Goldman, Myla, Jubelt, Burk, Lava, Neil, Lynch, Sharon, Miravalle, Augusto, Moses, Harold, Ontaneda, Daniel, Perumal, Jai, Racke, Michael, Repovic, Pavle, Riley, Claire, Severson, Christopher, Shinnar, Shlomo, Suski, Valerie, Weinstock-Gutman, Bianca, Yadav, Vijayshree, Zabeti, Aram
Publicado no Contemp Clin Trials (2016)

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

Por Fox, Robert J., Coffey, Christopher S., Conwit, Robin, Cudkowicz, Merit E., Gleason, Trevis, Goodman, Andrew, Klawiter, Eric C., Matsuda, Kazuko, McGovern, Michelle, Naismith, Robert T., Ashokkumar, Akshata, Barnes, Janel, Ecklund, Dixie, Klingner, Elizabeth, Koepp, Maxine, Long, Jeffrey D., Natarajan, Sneha, Thornell, Brenda, Yankey, Jon, Bermel, Robert A., Debbins, Josef P., Huang, Xuemei, Jagodnik, Patricia, Lowe, Mark J., Nakamura, Kunio, Narayanan, Sridar, Sakaie, Ken E., Thoomukuntla, Bhaskar, Zhou, Xiaopeng, Krieger, Stephen, Alvarez, Enrique, Apperson, Michelle, Bashir, Khurram, Cohen, Bruce A., Coyle, Patricia K., Delgado, Silvia, Dewitt, L. Dana, Flores, Angela, Giesser, Barbara S., Goldman, Myla D., Jubelt, Burk, Lava, Neil, Lynch, Sharon G., Moses, Harold, Ontaneda, Daniel, Perumal, Jai S., Racke, Michael, Repovic, Pavle, Riley, Claire S., Severson, Christopher, Shinnar, Shlomo, Suski, Valerie, Weinstock-Guttman, Bianca, Yadav, Vijayshree, Zabeti, Aram
Publicado no N Engl J Med (2018)